Harrow, Inc. has grown revenue 43% a year over three years and 39% a year over five. Revenue growth, 3-year annual rate: +43% (Drug Manufacturers - Specialty & Generic median +15%). Revenue growth, 5-year rate: +39%, growth has picked up over the last three years. Years of annual history on file: 27, FY1999 to FY2025, as filed.

HROWHarrow, Inc.

HealthcareUSD

$39.32

$29.0352 weeks$54.80

Is it growing?

Is HROW growing?

Harrow, Inc. has grown revenue 43% a year over three years and 39% a year over five.

+43%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +15% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +39%
Revenue growth, 5-year rate · +43% over three · growth has picked up over the last three years
Years of annual history on file: 27
Years of annual history on file · FY1999 to FY2025, as filed

Details›